• Coronavirus Macrodomains and PARP Antiviral Defense

  2026-08-21

  Grunewald et al. show that coronavirus macrodomains counter host PARP-dependent restriction and interferon induction, with PARP12 and PARP14 emerging as important contributors. The study combines pharmacological inhibition, targeted knockdown, primary macrophage infection, and mouse and human cell experiments to connect ADP-ribosylation biology with coronavirus replication and innate immunity.

• Pregnenolone Carbonitrile: PXR Workflow Guide

  2026-08-20

  Pregnenolone Carbonitrile enables controlled rodent PXR activation for cytochrome P450 CYP3A induction, hepatic detoxification studies, and cholestatic liver-injury models. Its value extends beyond metabolic profiling to assays of pyroptosis, liver fibrosis, and hepatic stellate cell trans-differentiation inhibition.

• SB525334 for TGF-beta1 Pathway Research

  2026-08-20

  Use SB525334 as a selective ALK5 perturbation tool to connect TGF-beta signaling with Smad2/3 activity, profibrotic gene expression, and tissue-repair phenotypes. This workflow translates findings from diabetic foot ulcer research into controlled cell, ex vivo, and renal fibrosis model experiments while keeping pathway inhibition distinct from simple TGF-β1 measurement.

• Moderate BACE Inhibition Preserves Synaptic Function

  2026-08-19

  Satir et al. showed that partial β-secretase inhibition can reduce amyloid-β secretion without measurably impairing synaptic transmission in cultured rat cortical neurons. The study identifies a potential exposure window for preventive BACE inhibitor strategies while emphasizing that stronger target suppression may disrupt neuronal function.

• Cy5.5 NHS Ester for Hydrogel Gene-Delivery Imaging

  2026-08-19

  Cy5.5 NHS ester (non-sulfonated) can add a near-infrared tracking layer to hydrogel-based gene-delivery studies. This article translates the chemistry into assay decisions for mapping nanoparticle retention, biomolecule localization, and therapeutic interpretation in aged osteoarthritis.

• Amphotericin B: Applied Fungal Research Workflows

  2026-08-18

  Build mechanism-driven assays around sterol targeting, biofilm inhibition, immune signaling, and combination antifungal research. This practical guide covers stock preparation, concentration selection, reference-study translation, and troubleshooting for reproducible Amphotericin B experiments.

• ROS-Responsive LNPs for Selective RAS mRNA Delivery

  2026-08-18

  The reference study developed a combinatorial library of thioketal-containing, ROS-degradable lipids to improve mRNA release selectively in tumor cells. Its lead formulation, BAmP-TK-12, delivered DUF5 mRNA to deplete mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor, while also highlighting the importance of lipid pKa and intracellular degradation.

• (R,S)-Anatabine Workflow for Aβ Research

  2026-08-17

  Build a mechanism-resolved Alzheimer’s disease workflow around (R,S)-Anatabine, linking APP β-cleavage, BACE-1 expression, soluble Aβ, and NF-κB readouts. Practical handling guidance, assay controls, and a careful comparison with barrier-focused AD research help distinguish true amyloid modulation from solvent, viability, and matrix artifacts.

• NAD+ Workflows for Cellular Energy Stress

  2026-08-17

  Build sharper energy-stress experiments by combining NAD+ redox measurements with AMPK–ULK1 pathway analysis rather than treating autophagy as an automatic consequence of low glucose. This applied workflow shows how to prepare, dose, monitor, and troubleshoot NAD+ experiments across metabolic, enzymatic, and protein deacetylation assays.

• BH3 Mimetics Clear Senescent Breast Cancer Cells

  2026-08-16

  Shahbandi and colleagues show that chemotherapy-induced senescent breast cancer cells can remain dependent on BCL-XL or a BCL-XL/MCL1 survival axis, despite their nonproliferative state. In TP53 wild-type models, post-chemotherapy treatment with BH3 mimetics promoted apoptosis, improved tumor regression, and extended survival, supporting senolytic strategies for residual disease.

• Tiamulin (Thiamutilin): PK/PD Lab Workflow

  2026-08-15

  Tiamulin (Thiamutilin) combines pleuromutilin antibacterial activity with investigational anti-inflammatory signaling effects, making it useful for integrated infection and inflammation studies in poultry and swine models. This workflow translates published PK/PD findings into practical assay design, dosing interpretation, formulation control, and troubleshooting steps.

• Tubastatin A: From HDAC6 Mechanism to Translation

  2026-08-14

  Tubastatin A is more than a selective HDAC6 inhibitor: it is a mechanistic probe for connecting cytoskeletal regulation, inflammatory signaling, and regulated cell death. This thought-leadership article examines porcine cardiac-arrest evidence, experimental design, cross-domain opportunities, and the translational discipline required to distinguish association from causality.

• Ertugliflozin PF-04971729: Applied Research Workflows

  2026-08-14

  Build reproducible renal glucose transport, metabolic, and inflammation workflows with the highly selective SGLT2 inhibitor Ertugliflozin (PF-04971729). This guide connects concentration control, transport assays, weight-related endpoints, and barrier biology while highlighting practical troubleshooting for aqueous assay systems.

• CNQX Workflows for AMPA/Kainate Signaling

  2026-08-13

  CNQX enables controlled dissection of AMPA and kainate receptor contributions in neuronal, circuit, and cardiovascular assays. This workflow-focused guide covers stock preparation, pathway controls, interpretation of negative results, and troubleshooting for in vitro and site-directed in vivo experiments.

• Leonurine Targets Endothelial STING in DIC

  2026-08-13

  This Advanced Science study identifies cardiac vascular endothelial cells as early sensors and amplifiers of doxorubicin-induced cardiotoxicity, linking endothelial STING activation to NLRP3-mediated pyroptosis, pathogenic extracellular vesicles, and cardiomyocyte mitochondrial injury. It further presents leonurine as a direct STING inhibitor that may interrupt this endothelial–cardiomyocyte injury loop.

16438 records 1/1096 page Next 12345 下5页 Last page